Cargando…

Metastases with definitive pathological diagnosis but no detectable primary tumor: A surveillance epidemiology and end results‐based study

BACKGROUND: This study investigates the characteristics of a special type of cancer of unknown primary site (CUP, type 2), which is a metastasis of a definite pathological diagnosis without a detectable primary site. PATIENTS AND METHODS: Patients diagnosed between 2004 and 2014 were identified from...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Lianyuan, Yu, Haibo, Dong, Yadong, Tian, Guanjing, Ren, Zhiyuan, Li, Deyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792521/
https://www.ncbi.nlm.nih.gov/pubmed/31407505
http://dx.doi.org/10.1002/cam4.2496
_version_ 1783459174914457600
author Tao, Lianyuan
Yu, Haibo
Dong, Yadong
Tian, Guanjing
Ren, Zhiyuan
Li, Deyu
author_facet Tao, Lianyuan
Yu, Haibo
Dong, Yadong
Tian, Guanjing
Ren, Zhiyuan
Li, Deyu
author_sort Tao, Lianyuan
collection PubMed
description BACKGROUND: This study investigates the characteristics of a special type of cancer of unknown primary site (CUP, type 2), which is a metastasis of a definite pathological diagnosis without a detectable primary site. PATIENTS AND METHODS: Patients diagnosed between 2004 and 2014 were identified from the Surveillance Epidemiology and End Results (SEER) database. The characteristics of type 2 CUP from different sources were analyzed. For each source of type 2 CUP, tumors of the corresponding T(n)N(0‐X)M(1) stage were used as controls. RESULTS: A total of 8505 patients with type 2 CUP were included in this analysis. Type 2 CUP shows an increasing trend, while type 1 shows the opposite. Type 2 CUPs have significant differences with stage IV of the same pathological primary lesion. Many characteristics influenced the prognosis of type 2 CUP patients, including marital status, age, race, sex, registration time, lymph node metastasis, surgery, chemotherapy, and radiation. CONCLUSION: Our study suggests that identifying the source of metastasis is the key to the selection of treatment and the determination of the prognosis for CUP.
format Online
Article
Text
id pubmed-6792521
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-67925212019-10-21 Metastases with definitive pathological diagnosis but no detectable primary tumor: A surveillance epidemiology and end results‐based study Tao, Lianyuan Yu, Haibo Dong, Yadong Tian, Guanjing Ren, Zhiyuan Li, Deyu Cancer Med Clinical Cancer Research BACKGROUND: This study investigates the characteristics of a special type of cancer of unknown primary site (CUP, type 2), which is a metastasis of a definite pathological diagnosis without a detectable primary site. PATIENTS AND METHODS: Patients diagnosed between 2004 and 2014 were identified from the Surveillance Epidemiology and End Results (SEER) database. The characteristics of type 2 CUP from different sources were analyzed. For each source of type 2 CUP, tumors of the corresponding T(n)N(0‐X)M(1) stage were used as controls. RESULTS: A total of 8505 patients with type 2 CUP were included in this analysis. Type 2 CUP shows an increasing trend, while type 1 shows the opposite. Type 2 CUPs have significant differences with stage IV of the same pathological primary lesion. Many characteristics influenced the prognosis of type 2 CUP patients, including marital status, age, race, sex, registration time, lymph node metastasis, surgery, chemotherapy, and radiation. CONCLUSION: Our study suggests that identifying the source of metastasis is the key to the selection of treatment and the determination of the prognosis for CUP. John Wiley and Sons Inc. 2019-08-13 /pmc/articles/PMC6792521/ /pubmed/31407505 http://dx.doi.org/10.1002/cam4.2496 Text en © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Cancer Research
Tao, Lianyuan
Yu, Haibo
Dong, Yadong
Tian, Guanjing
Ren, Zhiyuan
Li, Deyu
Metastases with definitive pathological diagnosis but no detectable primary tumor: A surveillance epidemiology and end results‐based study
title Metastases with definitive pathological diagnosis but no detectable primary tumor: A surveillance epidemiology and end results‐based study
title_full Metastases with definitive pathological diagnosis but no detectable primary tumor: A surveillance epidemiology and end results‐based study
title_fullStr Metastases with definitive pathological diagnosis but no detectable primary tumor: A surveillance epidemiology and end results‐based study
title_full_unstemmed Metastases with definitive pathological diagnosis but no detectable primary tumor: A surveillance epidemiology and end results‐based study
title_short Metastases with definitive pathological diagnosis but no detectable primary tumor: A surveillance epidemiology and end results‐based study
title_sort metastases with definitive pathological diagnosis but no detectable primary tumor: a surveillance epidemiology and end results‐based study
topic Clinical Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792521/
https://www.ncbi.nlm.nih.gov/pubmed/31407505
http://dx.doi.org/10.1002/cam4.2496
work_keys_str_mv AT taolianyuan metastaseswithdefinitivepathologicaldiagnosisbutnodetectableprimarytumorasurveillanceepidemiologyandendresultsbasedstudy
AT yuhaibo metastaseswithdefinitivepathologicaldiagnosisbutnodetectableprimarytumorasurveillanceepidemiologyandendresultsbasedstudy
AT dongyadong metastaseswithdefinitivepathologicaldiagnosisbutnodetectableprimarytumorasurveillanceepidemiologyandendresultsbasedstudy
AT tianguanjing metastaseswithdefinitivepathologicaldiagnosisbutnodetectableprimarytumorasurveillanceepidemiologyandendresultsbasedstudy
AT renzhiyuan metastaseswithdefinitivepathologicaldiagnosisbutnodetectableprimarytumorasurveillanceepidemiologyandendresultsbasedstudy
AT lideyu metastaseswithdefinitivepathologicaldiagnosisbutnodetectableprimarytumorasurveillanceepidemiologyandendresultsbasedstudy